Weisheng Chen

Company: Leveragen

Job title: Founder & Chief Executive Officer


Singularity Sapiens: A Novel Genetically Engineered Mouse for Developing Fully Human Nanobodies and Multi-specific Antibodies 9:35 am

– Using cutting-edge gene editing and targeted replacement technologies to engineer the Singularity Sapiens Mouse that produces fully human heavy chain only antibodies – A rapid NGS-driven approach coupled with high-throughput recombinant expression screens has been established to identify target-specific binders for developing fully human nanobody-based next generation biologicsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.